Abstract
During the last years, many new technologies, like laparoscopy, endoscopy, and robotics, have been introduced in surgery to improve daily practice. Among these techniques, “fluorescence-guided surgery” (FGS) is an intraoperative imaging system allowing the identification of structures through fluorescent probes and dedicated technology. The main aim is to improve surgical guidance. This chapter will discuss the history of immunofluorescence, basic principles of fluorescence, fluorescent probes in surgery, and clinical imaging systems.
Since its first clinical application in the surgical field in 1947, fluorescence has undergone a huge development and diffusion. To date, fluorescence has several applications in every surgical specialty like perfusion assessment, cholangiography, lymphography, tumor identification, and ureter identification.
The technique implies the administration of a fluorescent probe that is excited by light excitation source and emitted by dedicated instruments, with consequent emission of a fluorescent signal that is detected and visualized on a screen. Among the fluorescent probes already approved for clinical use, like methylene blue, fluorescein sodium, and 5-aminolevulinic acid, the most diffused is indocyanine green (ICG). ICG has some peculiar features that promote its widespread use: it is virtually harmless, due to the lowest rate of adverse effects reported and to the very high toxic dose for the human body, and it is not expensive. Many probes are currently under clinical development and will be on the market soon.
A growing number of companies developed new systems for FGS with excitation and emission spectra in the nearinfrared wavelength range, which are suitable for both fluorescence and white light imaging.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Gioux S, Choi HS, Frangioni JV. Image-guided surgery using invisible near-infrared light: fundamentals of clinical translation. Mol Imaging. 2010;9(5):237–55.
Howell JD. Early clinical use of the x-ray. Trans Am Clin Climatol Assoc. 2016;127:341–9.
Pogue BW. Optics of medical imaging: optics plays dominant role in medical imaging market. In: SPIE professional, 2018. p. 6–8.
Stewart HL, Birch DJS. Fluorescence guided surgery. Methods Appl Fluoresc. 2021;9:4.
National Research Council. Medical optical imaging mathematics and physics of emerging biomedical imaging. Washington DC: National Academy Press; 1996. https://doi.org/10.17226/5066.
Orosco RK, Tsien RY, Nguyen QT. Fluorescence imaging in surgery. IEEE Rev Biomed Eng. 2013;6:178–87.
Nguyen QT, Tsien RY. Fluorescence-guided surgery with live molecular navigation--a new cutting edge. Nat Rev Cancer 2013;13(9):653–662.
Dip FD, Ishizawa T, Kodudo N, Rosenthal RJ. Fluorescence imaging for surgeons concepts and applications. Basel: Springer; 2015. p. 3–23. ISBN: 978-3-319-35213-8.
Moore GE. Fluorescein as an agent in the differentiation of normal and malignant tissues. Science. 1947;106:130–1.
Lay CL, Randall LM. Fluorescent staining for detection of cancer cells in vaginal smears. Surg Forum. 1953:321–7.
Raymond J, Lanzafame MD, David W, Rogers BS, John O, Nairn MS, et al. Hematoporphyrin derivative fluorescence: photographic techniques for the localization of malignant tissue. Lasers Surg Med. 1986;6(3):328–35.
Ahlquist RE Jr, Figge FH. Fluorescence of the extrahepatic biliary system following parenteral hematoporphyrin administration. Surg Forum. 1956;6:356–8.
Ackermann NB, Mc Fee AS. Tetracycline fluorescence in benign and malignant tissues. Surgery. 1963;53:247–52.
Sandlow LJ, Allen HA. The use of tetracycline fluorescence in the detection of gastric malignancy. Ann Intern Med. 1963;58(3):409–13.
Whitmore WF Jr, Bush IM. Ultraviolet cystoscopy in patients with bladder cancer. Trans Am Assoc Genitourin Surg. 1965;57:149–55.
Málek P, Kolc J, Pultr V, Zástava V. Tetracycline fluorescence test in evaluation of ischemic changes in kidney transplantations. Rozhl Chir. 1966;45(4):252–6.
Cassini MF, da Costa MM. Fluorescence spectroscopy in renal ischemia and reperfusion: noninvasive evaluation of organ viability. Transplant Proc. 2013;45(5):1715–9.
Nessel E, Wiggermann W. The tetracycline fluorescence test in surgery of malignant tumors; rhinolaryngologic experiences. HNO. 1965;13(12):346–9.
Goldhahn WE. Fluorescence studies of brain tumors. Beitr Neurochir. 1966;13:126–9.
Khutsishili TS, Milaeva MA. The use of the fluorescent method for determining the degree of revascularization of the heart in the surgical treatment of experimental cardiac ischemia. Grudn Khir. 1965;7(6):11–2. Russian.
Loisance D, Sadony V. Value of fluorescence in the macroscopic delimitation of experimental acute myocardial ischemia before and after revascularization. Arch Mal Coeur Vaiss 1973;66(6):701–707.
Zhang RR, Schroeder AB, Grudzinski JJ, Rosenthal EL, Warram JM, Pinchuk AN, et al. Beyond the margins: real-time detection of cancer using targeted fluorophores. Nat Rev Clin Oncol. 2017;14(6):347–64.
Mordon S, Devoisselle JM, Soulie-Begu S, Desmettre T. Indocyanine green: physicochemical factors affecting its fluorescence in vivo. Microvasc Res. 1998;55:146–52.
Desmettre T, Devoisselle JM, Mordon S. Fluorescence properties and metabolic features of indocyanine green (ICG) as related to angiography. Surv Ophthalmol. 2000;45:15–27.
Valeur B, Berberan-Santos MN. Molecular fluorescence: principles and applications. Weinheim: Wiley-VCH; 2012. ISBN: 978-3-527-32837-6.
Lakowicz JR. Principles of fluorescence spectroscopy. New York, NY: Springer; 2010. ISBN: 978-1-4615-7658-7.
Azzopardi EA, Owens SE, Murison M, Rees D, Anne Sawhney M, Francis LW, et al. Chromophores in operative surgery: current practice and rationalized development. J Control Release. 2017;249:123–30.
Rashid A, Warnakulasuriya S. The use of light-based (optical) detection systems as adjuncts in the detection of oral cancer and oral potentially malignant disorders: a systematic review. J Oral Pathol Med. 2015;44(5):307–28.
de Boer E, Harlaar NJ, Taruttis A, Nagengast WB, Rosenthal EL, Ntziachristos V, van Dam GM. Optical innovations in surgery. Br J Surg. 2015;102(2):e56–72.
Fernandez-Suarez M, Ting AY. Fluorescent probes for super-resolution imaging in living cells. Nat Rev Mol Cell Biol. 2008;9(12):929–43.
Mondal SB, et al. Real-time fluorescence image-guided oncologic surgery. Adv Cancer Res. 2014;124:171–211.
Marmorstein AD, Marmorstein LY, Sakaguchi H, Hollyfield JG. Spectral profiling of autofluorescence associated with lipofuscin, Bruch’s membrane, and sub-RPE deposits in normal and AMD eyes. Invest Ophthalmol Vis Sci. 2002;43(7):2435–41.
Shin D, Vigneswaran N, Gillenwater A, Richards-Kortum R. Advances in fluorescence imaging techniques to detect oral cancer and its precursors. Future Oncol. 2010;6:1143–54.
Selvam S, Sarkar I. Bile salt induced solubilization of methylene blue: study on methylene blue fluorescence properties and molecular mechanics calculation. J Pharm Anal. 2017;7:71–5.
Matsui A, Tanaka E, Choi HS, Kianzad V, Gioux S, Lomnes SJ, Frangioni JV. Real-time, near-infrared, fluorescence-guided identification of the ureters using methylene blue. Surgery. 2010;148:78–86.
Alander JT, Kaartinen I, Laakso A, Pätilä T, Spillmann T, Tuchin VV, et al. A review of indocyanine green fluorescent imaging in surgery. Int J Biomed Imaging. 2012;2012:940585.
Schaafsma BE, Mieog JS, Hutteman M, vad der Vorst JR, Kuppen PJ, Lowik CW, et al. The clinical use of indocyanine green as a near-infrared fluorescent contrast agent for image-guided oncologic surgery. J Surg Oncol. 2011;104:323–32.
Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol. 2006;7(5):392–401.
Staderini M, Megia-Fernandez A, Dhaliwal K, Bradley M. Peptides for optical medical imaging and steps towards therapy. Bioorg Med Chem. 2018;26:2816–26.
Hoogstins CES, Boogerd LSF, Sibinga Mulder BG, Mieog JSD, Swijnenburg RJ, van de Velde CJH, et al. Image-guided surgery in patients with pancreatic cancer: first results of a clinical trial using SGM-101, a novel carcinoembryonic antigen-targeting, near-infrared fluorescent agent. Ann Surg Oncol. 2018;25:3350–7.
Patil CG, Walker DG, Miller DM, Butte P, Morrison B, Kittle DS, et al. Phase 1 safety, pharmacokinetics, and fluorescence imaging study of Tozuleristide (BLZ-100) in adults with newly diagnosed or recurrent gliomas. Neurosurgery. 2019;85:E641–9.
Randall LM, Wenham RM, Low PS, Dowdy SC, Tanyi JL. A phase II, multicenter, open-label trial of OTL38 injection for the intra-operative imaging of folate receptor-alpha positive ovarian cancer. Gynecol Oncol. 2019;155:63–8.
Luo S, Zhang E, Su Y, Cheng T, Shi C. A review of NIR dyes in cancer targeting and imaging. Biomaterials. 2011;32:7127–38.
Engelborghs Y, Visser AJWG. Fluorescence spectroscopy and microscopy: methods and protocols. Methods Mol Biol. 2014. https://doi.org/10.1007/978-1-62703-649-8.
Sevick-Muraca EM, Houston JP, Gurfinkel M. Fluorescence-enhanced, nearinfrared diagnostic imaging with contrast agents. Curr Opin Chem Biol. 2002;6:642–50.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Baldari, L., Boni, L., Cassinotti, E. (2023). History and Science of Immunofluorescence. In: Szoka, N., Renton, D., Horgan, S. (eds) The SAGES Manual of Fluorescence-Guided Surgery. Springer, Cham. https://doi.org/10.1007/978-3-031-40685-0_1
Download citation
DOI: https://doi.org/10.1007/978-3-031-40685-0_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-40684-3
Online ISBN: 978-3-031-40685-0
eBook Packages: MedicineMedicine (R0)